Article
Holland & Knight Health Dose: September 22, 2026
The U.S. Senate prepares for critical healthcare leadership votes while stakeholders debate reforms to the No Surprises Act amid growing concerns over dispute resolution backlogs and payment transparency. Federal agencies advance new initiatives spanning AI-enabled cardiovascular care, expedited drug development pathways, and expanded chronic care models as Congress weighs potential policy changes affecting physician reimbursement, telehealth access, and Medicaid drug pricing.
Holland & Knight